clinical trial · NCT06564142
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Alpine Immune Sciences Inc, A Subsidiary of Vertex·phase3·active not recruiting·n = 605
Immunoglobulin A NephropathyPovetaciceptPlacebo (matched to Povetacicept)
brief summary
The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserving renal function.
started
Aug 30, 2024
primary completion
Jan 30, 2028
completion
Jan 30, 2028
last updated
Dec 17, 2025
official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol